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ABSTRACT
Objectives It has been hypothesised that ectopy may
be associated with increased susceptibility to sexually
transmitted infections (STIs). In this cross-sectional study,
we wanted to explore the association between STIs
(including HIV) and cervical ectopy.
Methods We included 700 sexually active young
women attending randomly selected high schools in a
rural district in KwaZulu-Natal, South Africa. The district
is endemic of HIV and has a high prevalence of STIs. We
did computer-assisted measurements of the ectocervical
area covered by columnar epithelium (ectopy) in
colposcopic images and STI analyses on cervicovaginal
lavage and serum samples. All participating women
answered a questionnaire about sexual behaviour and
use of contraceptives.
Results The mean age was 19.1 years. Ectopy was
found in 27.2%, HIV in 27.8%, chlamydia in 25.3%
and gonorrhoea in 15.6%. We found that age, parity,
chlamydia and gonorrhoea, years since menarche, years
since sexual debut and number of sexual partners were
associated with ectopy. In multivariate analysis with
chlamydia infection as the dependent variable, women
with ectopy had increased odds of having chlamydia
infection (adjusted OR 1.78, p=0.033). In women under
19 years of age, we found twofold higher odds of being
HIV-positive for those with ectopy (OR 2.19, p=0.014).
Conclusions In conclusion, cervical ectopy is
associated with Chlamydia trachomatis infection and HIV
in the youngest women.
INTRODUCTION
Young women carry a disproportionally high risk
of contracting sexually transmitted infections (STI)
including HIV.1 2 A complex relationship between
sexual behaviour and biological risk factors contrib-
ute to this tendency.3 Cervical ectopy, the presence
of columnar epithelium on the ectocervix, has been
suggested to inﬂuence women’s susceptibility to
STIs.4
Ectopy occurs when the columnar epithelium,
normally found in the endocervical channel,
extends onto the ectocervix. This epithelium con-
sists of a single layer of columnar cells in contrast
with the stratiﬁed (multilayer) squamous epithelium
covering the rest of the ectocervical surface.5
Ectopy is commonly seen in young women.5 6
During and after puberty, the process of metaplasia
transforms the columnar epithelium into squamous
epithelium and the cervical ectopy decreases.5
Epidemiological studies have found an associ-
ation between cervical ectopy and infection with
Chlamydia trachomatis.4 7–9 This intracellular bac-
terium resides in columnar epithelial cells, making
cervical ectopy a favourable condition for infec-
tion.7 It has been hypothesised that hormonal con-
traceptives may further enhance this susceptibility,
as they have been shown to be associated with both
increased ectopy and chlamydia infection.9–11
Several studies have also found an association
between ectopy and HIV infection, but the topic
remains controversial.4 6 12 13 Female genital schis-
tosomiasis (FGS) has been shown to be associated
with HIV in cross-sectional studies, 14 but to our
knowledge, there have been no studies on the asso-
ciation with cervical ectopy. The ectocervical area
covered by columnar epithelium is usually esti-
mated subjectively by the investigating clinician,
whereas computer assisted measurement of the area
on colposcopic images has been shown to be a
more reliable method.15 16
In this study of young women, we investigated
the relationship between objectively measured
ectopy and common reproductive tract infections.
Due to the cross-sectional design of the study we
could not explore causality. However, it seems bio-
logically plausible that cervical ectopy may be asso-
ciated with increased susceptibility to STIs. To our
knowledge, this is the ﬁrst study investigating
ectopy in young women in an area with high preva-
lence of STIs including HIV.
MATERIALS AND METHODS
Enrolment
The participants were recruited in 2010–2012
from an ongoing study in coastal KwaZulu-Natal,
South Africa, focusing on various aspects of FGS
and STIs. Of the women (n=1074, ﬁgure 1) who
visited the research clinic during this time period,
all who had an image taken during the gynaeco-
logical exam that met the inclusion criteria
(n=700) were included in this cross-sectional study.
Young women from 31 randomly selected high
schools were invited. All included women were
sexually active and in their ﬁnal years of high
school. Women were not recruited based on
symptoms.
The rural district on the east coast is one of the
poorest in South Africa, endemic for urogenital
schistosomiasis and has a high prevalence of HIV,
chlamydia, gonorrhoea and trichomoniasis.
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Clinical investigation and questionnaire
The study participants were interviewed by trained research
assistants. The questionnaire was in the local language (isiZulu)
and included questions on behavioural factors (including sexual
behaviour, alcohol and drug use), contraceptives, obstetric
history and urogenital symptoms.
Gynaecological examinations with colposcopy were per-
formed by two female medical doctors (EK and KL). Pregnant
women were not investigated. Cervicovaginal lavage (CVL)
samples were collected by spraying 10 mL of saline on the
cervix four times before drawing it back into a syringe and
depositing it into tubes for frozen storage. Blood was collected
into sterile acid-citrate-dextrose anticoagulated Vacutainer tubes.
The examinations were documented using an Olympus OCS
500 colposcope with a mounted Olympus E 420 10 megapixel
(Mpx) single lens reﬂex (SLR) device, or a Leisegang colposcope
with a Canon EOS 40D 10 Mpx SLR. The image ﬁles were
stored using high-quality JPEG compression along with data
from the clinical investigation.
Image material
During the inclusion period, a total of 781 women underwent
gynaecological examination with acquisition of colposcopic
images. One image was selected per patient based on the follow-
ing inclusion criteria: at least 25% of the ectocervical surface
was visible, the cervical os was visible, a part of the cervical
curvature was visible, and the focus was adequate for identifying
anatomical landmarks. During the measurements, images were
excluded if there was heavy inﬂammation rendering the evalu-
ation impossible or if there was a non-cervical element render-
ing the extent of ectopy non-evaluable (such as blood, discharge
or a medical instrument). The best image was chosen independ-
ent of whether it was taken before or after sampling for Pap
smear, cervico-vaginal lavage or application of acetic acid.
Computer assisted measurement of cervical ectopy
All measurements were performed using the open source image
analysis software ImageJ (US National Institutes of Health).
It allows for a visually guided delimitation of structures and a
subsequent measurement of the selected area (ﬁgure 2). We
further calculated the ectopy as a fraction of the total
Figure 1 Flowchart showing inclusion of images.
Figure 2 A photocolposcopic image of the ectocervix. Solid line:
Delimiting the cervical area. Dashed line: Original squamocolumnar
junction, outer delimitation of the transformation zone. Dotted line:
Current squamocolumnar junction, represents the border between
columnar epithelium and metaplastic squamous epithelium in the
transformation zone.
Epidemiology
Kleppa E, et al. Sex Transm Infect 2015;91:124–129. doi:10.1136/sextrans-2014-051674 125
group.bmj.com on January 18, 2016 - Published by http://sti.bmj.com/Downloaded from 
ectocervical area. Finally, the images were saved with the meas-
urement overlays for veriﬁcation and adjustment by a senior
gynaecologist (MO).
The ectocervical area was delimited by using the cervical os as
the centre of an elliptical shape that was manually ﬁtted to
conform to the visible cervical boundaries. The original
squamocolumnar junction was deﬁned as the outer delimitation
of any of the following structures: glandular openings,
Nabothian cysts and primary rugae extending from the cervical
os. In cases where such anatomical landmarks were absent or
too sparse, the original squamocolumnar junction was not mea-
sured. Finally, the current squamocolumnar junction (conﬁning
the area of ectopy) was deﬁned as a distinct transition of colour
from deep red to brighter red: The columnar epithelium is
single layered and appears dense red whereas the transformation
zone is covered in squamous epithelium, appearing brighter in
colour.
In cases where the original or current squamocolumnar junc-
tions were partially masked by medical instruments, blood or as
a result of the angle of inspection or photographic section, the
analysis of the ectocervix was divided into sectors. The largest
sector(s) in which it was possible to demarcate the squamocol-
umnar junction was used as a basis for estimating the squamo-
columnar junction that was impossible to measure.
The output of the measurements was in numbers of squared
pixels. The focal distance of each image was unknown. In conse-
quence, it was impossible to convert the computer measure-
ments into absolute values of squared millimetres. All
measurements were, therefore, converted to fractions of the
total ectocervical area, thus representing relative values. In pre-
vious studies, a cut-off level of 10% of the cervical area covered
by columnar epithelium has been used to deﬁne a cervix as
having ectopy.6 12 The investigators were blinded to the
patients’ STI results and questionnaire information.
Laboratory analyses
CVL samples were analysed by strand displacement assay for
Neisseria gonorrhoeae and C. trachomatis (ProbeTec CT/GT,
Becton, Dickinson and Company (BD), Franklin Lakes, New
Jersey, USA). A Gram stain was made from the CVL and scored
for bacterial vaginosis using Nugent’s scoring methodology.
PCR was used to screen for herpes simplex virus types 1 and 2
(HSV 1 and 2) and Trichomonas vaginalis (in-house PCR,
Laboratory of Infection, Prevention and Control, UKZN,
Durban, South Africa).17 18 Syphilis serology was performed
using rapid plasma reagin (Macro Vue test 110/112, BD) and
veriﬁcation was done using Treponema pallidum hemagglutin-
ation assay (Omega diagnostics Group PLC, Alva, Scotland,
UK). HIV serology was done using rapid test kits (Bioline Rapid
Test HIV, New Jersey, USA and Sensa Tri-Line HIV Test Kit,
Durban, South Africa). All serology was done on serum samples
frozen at −80°C.
Ethics
The study was approved by the Biomedical Research Ethics
Administration (BREC), University of KwaZulu-Natal, South
Africa 20 February 2009 (Ref BF029/07, renewed yearly) and
by the Provincial Department of Health, Pietermaritzburg,
South Africa on 3 February 2009 (Reference HRKM010-08).
The Regional Committee for Medical and Health Research
Ethics (REC) South Eastern Norway gave ethical clearance on
17 September 2007 (Ref 469-07066a1.2007.535). The
Departments of Health and Education in Ugu district,
KwaZulu-Natal also gave permissions.
Only sexually active women were invited. All participants
signed individual, written consent forms. The ethical commit-
tees, BREC and REC, were aware that 15-year-olds to
17-year-olds were participating in the study and speciﬁcally
approved the consent procedure (independent minor consent,
no parental consent). According to South African legislation,
persons over the age of 12 years could consent independently
to participate in research. Those who presented with symptoms,
signs or tested positive on subsequent laboratory analyses of
STIs were offered treatment in accordance with a South African
syndromic protocol. Partner treatment was also offered. HIV
testing and follow-up was done in accordance with South
African guidelines. HIV positive patients were referred to local
clinics for follow-up and antiretroviral treatment.
Anti-schistosomal treatment was offered to all.
Statistical analyses
Statistical analyses were performed using IBM SPSS Statistics
V.20 (SPSS, Armonk, New York, USA). Pearson’s χ2 test and
Fisher’s exact test were used to compare the characteristics of
women with and without ectopy. Univariate and multivariate
logistic regression models were constructed to analyse the asso-
ciations between ectopy, age, parity and gynaecological path-
ology. A signiﬁcance level of 5% was used throughout.
RESULTS
Out of 781 participants, 694 (88.9%) could be included in the
evaluation (ﬁgure 1). Mean age was 19.1 years and followed a
near normal distribution (SD 2.1, range 15–31). Half of the
women had given birth (383/682, 56.2%). Parous women had a
mean of 1.2 pregnancies (SD 0.6) and their mean age was 19.8
years (SD 2.0). Injectable contraceptives were used by 30.0% of
the women (204/681), while only 1.5% (10/680) used contra-
ceptive pills. At least one STI (not including HIV) was found in
306 women (60.6%). The HIV prevalence was 27.8% (159/
572). Only 9.1% (62/681) reported that they knew they were
HIV positive, of which 23.0% (14/61) reported to be on anti-
retroviral treatment (one did not answer).
Cervical ectopy
Ectopy, measured as a fraction of the total ectocervical area, did
not follow a normal distribution. The median degree of ectopy
was 4.0% (range 0.0%–69.5%). Using a 10% cut-off in deﬁning
ectopy, 27.2% (n=189) of the women had ectopy (table 1, Web
reference 1). Ectopy was associated with having been pregnant
(OR 3.11, 95% CI (2.14 to 4.52), p value <0.001). The level
of ectopy was also increasing with age (0.5% per year,
p=0.019). However, when adjusted for having given birth, no
age-dependent increase was found (p=0.83). The same ten-
dency was found for years since menarche, years since sexual
debut and number of lifetime sexual partners, which were sig-
niﬁcantly associated to degree of ectopy but not when adjusted
for having given birth.
Ectopy and C. trachomatis infection
Of the women with ectopy, 35.0% tested positive for genital
chlamydia infection as opposed to 21.6% of the women
without ectopy (OR 1.96, 95% CI (1.31 to 2.93), p=0.001).
Increasing ratio of ectopy was associated with an increasing OR
of having chlamydia infection (ﬁgure 3). Women with more
than 40% ectopy very often had chlamydia infection compared
with women without ectopy (OR 5.08, 95% CI (2.18 to
11.83), p<0.001).
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We ﬁtted a multivariate logistic regression model with chla-
mydia as the dependent variable, where we adjusted for other
STIs, age, condom use, number of partners and age at sexual
debut. We found that women with ectopy had almost twofold
increased odds of having chlamydia (adjusted OR (AOR) 1.78,
95% CI (1.05 to 3.01), p=0.033).
Ectopy and N. gonorrhoeae infection
Gonorrhoea was found more frequently in the ectopy group
(24.4%) than in the group without ectopy (17.0%, OR 1.57,
95% CI (1.01 to 2.46), p=0.046). None of the other STIs nor
FGS was signiﬁcantly associated with ectopy in univariate ana-
lysis (table 1). However, when adjusting for other STIs in a
multivariate regression model, gonorrhoea was not signiﬁcantly
associated with ectopy (AOR 1.15, 95% CI (0.70 to 1.88),
p=0.578).
Ectopy and HIV infection
For women under 19 years of age (n=282), we found an HIV
prevalence of 31.8% in women with ectopy as opposed to
17.6% in women without ectopy (OR 2.19, 95% CI (1.17 to
4.09), p=0.014, Web reference 1). There was no signiﬁcant
association between cervical ectopy and HIV in women over
19 years of age (p=0.452).
DISCUSSION
In this study, we found a twofold increase of the odds of being
HIV positive for the youngest women with ectopy.
Furthermore, we found that chlamydia infection was independ-
ently associated with ectopy.
A large, longitudinal study conducted in South Africa in 2006
determined that ectopy was a risk factor for HIV.13 They found
a weak association, and only for ectopy extending over 20% of
the cervical surface. The women were, however, participants of
a screening programme for cervical cancer and older than in
our study (>35 years). We observed a difference in the associ-
ation between ectopy and HIV infection between age groups. It
has previously been reported that young age is an independent
risk factor for acquisition of HIV.1 It is possible that the inﬂu-
ence of various HIV risk factors change during adolescence.
Table 1 Characteristics and test results of the study population comparing the group with cervical ectopy (≥10% of the area) to those without
ectopy
Ectopy (%)* No ectopy (%)* OR (95% CI) p Value†
Characteristics
Total 189 (100) 505 (100)
Age <19 81/188 (43) 276/496 (56) 0.60 (0.43 to 0.84) 0.003
Never been pregnant 47/187 (25) 252/495 (51)
Pregnant at least once 141/187 (75) 243/495 (49) 3.11 (2.14 to 4.52) <0.001
Years since menarche 0–4 66 (35) 210 (43)
5–6 65 (35) 167 (34) 1.24 (0.83 to 1.84) 0.293
≥7 57 (30) 115 (23) 1.58 (1.04 to 2.40) 0.034
Infections
Chlamydia trachomatis 55/157 (35) 89/412 (22) 1.96 (1.31 to 2.93) 0.001
HIV 53/165 (32) 106/407 (26) 1.34 (0.91 to 1.99) 0.142
Herpes simplex virus 6/158 (4) 26/408 (6) 0.58 (0.23 to 1.44) 0.239
Syphilis 6/147 (4) 9/344 (3) 1.58 (0.55 to 4.53) 0.388
Trichomonas vaginalis 40/170 (24) 87/424 (21) 1.19 (0.78 to 1.82) 0.419
Neisseria gonorrhoeae 38/156 (24) 70/412 (17) 1.57 (1.01 to 2.46) 0.046
Bacterial vaginosis 75/149 (50) 217/394 (55) 0.83 (0.57 to 1.21) 0.323
Any sexually transmitted infection‡ 102/150 (68) 204/355 (58) 1.57 (1.05 to 2.35) 0.027
Grainy sandy patch§ 28/189 (15) 70/505 (14) 1.08 (0.67 to 1.74) 0.748
Contraceptives
Contraceptive injection 61/187 (33) 143/494 (29) 1.19 (0.83 to 1.71) 0.350
Contraceptive pills 5/187 (3) 5/493 (1) 2.68 (0.77 to 9.37) 0.148¶
Condom use (last intercourse) 64/140 (46) 158/380 (42) 1.18 (0.80 to 1.75) 0.398
Behavioural factors
Number of lifetime partners ≥3 41/186 (22) 147/492 (30) 0.66 (0.45 to 0.99) 0.042
Alcohol, age at debut** ≤15 24/187 (13) 82/491 (17) 0.66 (0.39 to 1.11) 0.119
>15 83/187 (44) 229/491 (47) 0.82 (0.57 to 1.17) 0.272
Drugs (ever used) 11/188 (6) 51/494 (10) 0.54 (0.28 to 1.06) 0.069
Years since sexual debut ≥3 95/187 (51) 183/492 (37) 1.74 (1.24 to 2.45) 0.001
Age at sexual debut ≤15 52 (28) 112 (23)
16 49 (26) 167 (34) 0.63 (0.40 to 1.00) 0.049
≥17 86 (46) 215 (44) 0.86 (0.57 to 1.30) 0.480
Days since last intercourse ≤7 53/186 (28) 135/488 (28) 0.96 (0.66 to 1.40) 0.830
Anal sex 8/187 (4) 13/494 (3) 1.65 (0.67 to 4.06) 0.267
Forced sex 20/188 (11) 45/494 (9) 1.19 (0.68 to 2.07) 0.543
*Denominators vary according to specimens available for testing or missing answers in the questionnaire.
†χ2 test.
‡Not including HIV.
§Diagnosed by colposcopy, pathognomonic for female genital schistosomiasis.19
¶Fisher’s exact test.
**Those who reported to never have tasted alcohol served as reference group.
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Stratifying by age might help decipher risk factors in different
age groups. A challenge is the timing of HIV acquisition in rela-
tion to the ectopy, as there is a natural decrease of ectopy over
time.4 The youngest women in this population are likely to have
HIV seroconverted more recently and may therefore give a
better indication of risk factors present at the time of HIV acqui-
sition. The single-layered columnar epithelium may represent a
weaker physical barrier than the stratiﬁed squamous epithelium,
leaving a woman with ectopy at higher risk of HIV infection.4
Furthermore, HIV target cells have been found in greater abun-
dance in columnar than in squamous epithelium.4 Higher levels
of HIV viral shedding in the genital tract have also been asso-
ciated with ectopy.20
In accordance with other studies, we also found a strong asso-
ciation between ectopy and chlamydia infection.7 9 11 Due to
the cross-sectional design of this study, we cannot determine the
cause–effect relationship of the association. One longitudinal
study reported increased risk of C. trachomatis acquisition when
ectopy was present.9 It seems biologically plausible that a larger
area of columnar epithelium exposed on the ectocervical surface
may increase the risk of infection. Our data indicate a dose–
response relationship between ectopy and chlamydia infection
(ﬁgure 3). In the univariate analysis, both gonorrhoea and chla-
mydia infection was associated with ectopy. It has been sug-
gested that chlamydia shedding could be increased with
concurrent N. gonorrhoeae infection.21 Both these STIs may
lead to serious consequences for women and increased risk of
HIV acquisition.22 We did not ﬁnd a signiﬁcant association
between ectopy and syphilis, T. vaginalis, bacterial vaginosis,
HSVor FGS in univariate analysis (table 1).
Our ﬁnding that parity was associated with ectopy is in
accordance with previous studies.10 12 23 24 This can be
related to normal changes of the cervix caused by the delivery
or hormonal changes during pregnancy. This ﬁnding may indi-
cate that parity could inﬂuence a woman’s susceptibility to
STIs. The number of oral contraceptive users was too low to
draw any conclusion on the association with ectopy, but
contraceptive injections of progestogen were not associated
with ectopy.
Limitations
The size of the exposed columnar epithelium might depend on
the opening of the speculum. Parous women have a wider and
more open cervix and as a result, the ectopy could be overesti-
mated. Even though the columnar epithelium is generally easy
to distinguish from the surrounding squamous epithelium, we
cannot rule out the possibility that some areas of immature
metaplasia, inﬂammation or otherwise hyperaemic epithelium
could mimic ectopy and hence lead to an overestimation of the
area. In cases of doubt, the use of acetic acid was helpful.
The planimetric measuring tool provides relative numbers as
a fraction of the total ectocervical area. Although this gives an
indication of the degree of ectopy, which allows for comparison
with other subjects, it may be of more biological importance to
measure the absolute area of ectopy. This is only possible if the
exact depth of ﬁeld is known, but this information could not be
extracted from our images.
T. vaginalis, N. gonorrhoeae, C. trachomatis and HSV were
analysed in vaginal lavage samples. Similar methods have been
used in previous studies and have been validated for HSV and
T. vaginalis.17 18 25
Our analysis of N. gonorrhoeae and C. trachomatis in lavage
showed a similar ratio between the two infections compared to
previous reports from South Africa.26 27 Furthermore, the
DNA-based detection technique that was used for N. gonorrhoeae
and C. trachomatis is reported to have close to 100%
speciﬁcity.28
We did not collect information about the practice of vaginal
douching, which may be negatively associated with cervical
ectopy.11
Strengths
The study population was extensively explored for factors that
have previously been hypothesised to inﬂuence ectopy. As our
study participants were recruited from schools regardless of
symptoms, the participants were more likely representative of
the general population at this age than women attending health
facilities.
This study has the advantage that ectopy area calculations
were objective. Computer assisted planimetry on digital, colpo-
scopic images offered a precise and reproducible way of measur-
ing the relative area of ectopy on the cervix. The investigation
was performed at a point in time where there are almost no
adult survivors of mother-to-child HIV transmission, hence
almost all HIV infections were likely to have been sexually
transmitted. In this young population, it is therefore probable
that STIs including HIV infections occurred relatively recent to
our measurement of ectopy. As the degree of ectopy changes
over time, this temporal proximity of measurement is a clear
advantage.
CLINICAL RELEVANCE AND CONCLUSION
STIs and especially HIV have serious consequences for women.
The high prevalence of STIs including HIV in this group of
young women is worrying and warrants further studies.
Thorough knowledge about possible risk factors is needed.
Ectopy may be a biological risk factor for chlamydia infection
and for HIV in the young women. Treatment of ectopy by
methods like cryocauterisation and electrocoagulation has been
discussed, but the effect is still uncertain.29 Counselling on
barrier contraceptives might be of special importance when cer-
vical ectopy is found in young women at risk.
Figure 3 Graph showing the OR, with 95% CIs, of having Chlamydia
trachomatis infection (y-axis) with increasing levels of cervical ectopy
(x-axis). Participants without ectopy (<10%) serve as the reference
group.
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Key messages
▸ Columnar epithelium found on the ectocervical surface is
called ectopy and it can be a normal ﬁnding in young
women.
▸ Young women with ectopy were found to have more
Chlamydia trachomatis, Neisseria gonorrhoeae and HIV
infections.
▸ Ectopy may render the woman more susceptible to sexually
transmitted infections.
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